LeMaitre Vascular Q3 net income falls 13% to $15.02 million as sales rise 11%
LMAT•LeMaitre Vascular reported Q3 2026 net income of $15.02 million, down 13% year over year, while net sales rose 11% to $67.97 million. It forecast Q4 sales of $69.9 million–$71.9 million and EPS of $0.70–$0.75.
1. Quarterly results
LeMaitre Vascular’s Q3 2026 EPS fell 14% year over year to $0.65. Net sales rose 11% to $67.97 million, while operating expenses climbed 21% to $31.01 million.
2. Acquisition and outlook
In October, the company acquired certain B. Braun vascular assets for $19.2 million; customer transitions are expected to take 18–24 months. For Q4 2026, it projects EPS of $0.70–$0.75 and net sales of $69.9 million–$71.9 million.
